Scaling Allo with Allogene Therapeutics' Dr. Zachary Roberts
Cell & Gene: The Podcast
00:00
Exciting Developments in CAR T Therapy and Autoimmune Treatment
This chapter explores the groundbreaking advancements at Allogene Therapeutics, focusing on their promising alpha-3 trial and a phase one study that demonstrates significant efficacy in treating metastatic kidney cancer. Additionally, the discussion covers a novel CAR T product targeting autoimmune diseases, highlighting its innovative dual-targeting strategy for potential long-term remissions.
Transcript
Play full episode
